Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122834553 | 12283455 | 3 | F | 20160728 | 20160419 | 20160802 | EXP | US-ELI_LILLY_AND_COMPANY-US201604002942 | ELI LILLY AND CO | 71.00 | YR | F | Y | 0.00000 | 20160801 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122834553 | 12283455 | 1 | PS | PORTRAZZA | NECITUMUMAB | 1 | Intravenous (not otherwise specified) | 800 MG, CYCLICAL | Y | U | 125547 | 800 | MG | INJECTION | |||||
| 122834553 | 12283455 | 2 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | UNK UNK, CYCLICAL | Y | U | 0 | ||||||||
| 122834553 | 12283455 | 3 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | UNK UNK, CYCLICAL | Y | 0 | |||||||||
| 122834553 | 12283455 | 4 | C | LOFIBRA /00465701/ | 2 | U | 0 | ||||||||||||
| 122834553 | 12283455 | 5 | C | ATIVAN | LORAZEPAM | 1 | U | 0 | |||||||||||
| 122834553 | 12283455 | 6 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | U | 0 | |||||||||||
| 122834553 | 12283455 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 122834553 | 12283455 | 8 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 122834553 | 12283455 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | U | 0 | |||||||||||
| 122834553 | 12283455 | 10 | C | TIMOLOL. | TIMOLOL | 1 | U | 0 | |||||||||||
| 122834553 | 12283455 | 11 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 122834553 | 12283455 | 12 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 122834553 | 12283455 | 13 | C | REMERON | MIRTAZAPINE | 1 | U | 0 | |||||||||||
| 122834553 | 12283455 | 14 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | U | 0 | |||||||||||
| 122834553 | 12283455 | 15 | C | POTASSIUM | POTASSIUM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122834553 | 12283455 | 1 | Squamous cell carcinoma of lung |
| 122834553 | 12283455 | 2 | Squamous cell carcinoma of lung |
| 122834553 | 12283455 | 3 | Squamous cell carcinoma of lung |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122834553 | 12283455 | HO |
| 122834553 | 12283455 | OT |
| 122834553 | 12283455 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122834553 | 12283455 | Asthenia | |
| 122834553 | 12283455 | Confusional state | |
| 122834553 | 12283455 | Death | |
| 122834553 | 12283455 | Fatigue | |
| 122834553 | 12283455 | Generalised tonic-clonic seizure | |
| 122834553 | 12283455 | Malignant neoplasm progression | |
| 122834553 | 12283455 | Nausea | |
| 122834553 | 12283455 | Sepsis | |
| 122834553 | 12283455 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122834553 | 12283455 | 1 | 20160208 | 20160307 | 0 | |
| 122834553 | 12283455 | 2 | 20160208 | 0 | ||
| 122834553 | 12283455 | 3 | 20160208 | 0 |